PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb7
|
ENSMUSG00000038721.9 | Hoxb7 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb7 | mm39_v1_chr11_+_96177449_96177480 | -0.16 | 1.7e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_55407872 | 75.85 |
ENSMUST00000033915.9
|
Gpm6a
|
glycoprotein m6a |
chr13_+_83723255 | 61.04 |
ENSMUST00000199167.5
ENSMUST00000195904.5 |
Mef2c
|
myocyte enhancer factor 2C |
chr10_+_90412114 | 54.49 |
ENSMUST00000182427.8
ENSMUST00000182053.8 ENSMUST00000182113.8 |
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr12_+_29584560 | 54.39 |
ENSMUST00000021009.10
|
Myt1l
|
myelin transcription factor 1-like |
chr9_-_112016966 | 54.18 |
ENSMUST00000178410.2
ENSMUST00000172380.10 |
Arpp21
|
cyclic AMP-regulated phosphoprotein, 21 |
chrX_-_42256694 | 49.17 |
ENSMUST00000115058.8
ENSMUST00000115059.8 |
Tenm1
|
teneurin transmembrane protein 1 |
chr2_+_109522781 | 48.27 |
ENSMUST00000111050.10
|
Bdnf
|
brain derived neurotrophic factor |
chr12_-_31763859 | 47.21 |
ENSMUST00000057783.6
ENSMUST00000236002.2 ENSMUST00000174480.3 ENSMUST00000176710.2 |
Gpr22
|
G protein-coupled receptor 22 |
chr13_+_83723743 | 46.99 |
ENSMUST00000198217.5
ENSMUST00000199210.5 |
Mef2c
|
myocyte enhancer factor 2C |
chr13_+_42834039 | 46.74 |
ENSMUST00000128646.8
|
Phactr1
|
phosphatase and actin regulator 1 |
chr17_-_90395771 | 46.32 |
ENSMUST00000197268.5
ENSMUST00000173917.8 |
Nrxn1
|
neurexin I |
chr8_-_68427217 | 45.21 |
ENSMUST00000098696.10
ENSMUST00000038959.16 ENSMUST00000093469.11 |
Psd3
|
pleckstrin and Sec7 domain containing 3 |
chr15_+_18819033 | 44.99 |
ENSMUST00000166873.9
|
Cdh10
|
cadherin 10 |
chr3_+_68479578 | 44.88 |
ENSMUST00000170788.9
|
Schip1
|
schwannomin interacting protein 1 |
chr11_+_42312150 | 42.32 |
ENSMUST00000192403.2
|
Gabrb2
|
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
chr6_-_138404076 | 42.24 |
ENSMUST00000203435.3
|
Lmo3
|
LIM domain only 3 |
chr3_+_55369288 | 42.09 |
ENSMUST00000198412.5
ENSMUST00000199169.5 ENSMUST00000199702.5 ENSMUST00000198437.5 |
Dclk1
|
doublecortin-like kinase 1 |
chr2_+_61634797 | 39.13 |
ENSMUST00000048934.15
|
Tbr1
|
T-box brain transcription factor 1 |
chr6_-_55658242 | 38.85 |
ENSMUST00000044767.10
|
Neurod6
|
neurogenic differentiation 6 |
chr5_+_66833434 | 38.65 |
ENSMUST00000031131.11
|
Uchl1
|
ubiquitin carboxy-terminal hydrolase L1 |
chrX_-_58211440 | 38.45 |
ENSMUST00000119306.2
|
Fgf13
|
fibroblast growth factor 13 |
chr3_+_14011445 | 37.46 |
ENSMUST00000192209.6
ENSMUST00000171075.8 ENSMUST00000108372.4 |
Ralyl
|
RALY RNA binding protein-like |
chr5_+_20433169 | 36.38 |
ENSMUST00000197553.5
ENSMUST00000208219.2 |
Magi2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr1_-_79417732 | 36.22 |
ENSMUST00000185234.2
ENSMUST00000049972.6 |
Scg2
|
secretogranin II |
chr4_-_110149916 | 35.95 |
ENSMUST00000106601.8
|
Elavl4
|
ELAV like RNA binding protein 4 |
chr7_+_91321500 | 35.93 |
ENSMUST00000238619.2
ENSMUST00000238467.2 |
Dlg2
|
discs large MAGUK scaffold protein 2 |
chr11_-_41891662 | 35.65 |
ENSMUST00000070725.11
|
Gabrg2
|
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
chr2_-_57942844 | 34.61 |
ENSMUST00000090940.6
|
Ermn
|
ermin, ERM-like protein |
chr17_+_70829050 | 34.39 |
ENSMUST00000133717.9
ENSMUST00000148486.8 |
Dlgap1
|
DLG associated protein 1 |
chr9_-_29874401 | 34.26 |
ENSMUST00000075069.11
|
Ntm
|
neurotrimin |
chr15_-_37458768 | 34.25 |
ENSMUST00000116445.9
|
Ncald
|
neurocalcin delta |
chr15_-_8739893 | 34.03 |
ENSMUST00000157065.2
|
Slc1a3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr14_+_27598021 | 33.57 |
ENSMUST00000211684.2
ENSMUST00000210924.2 |
Erc2
|
ELKS/RAB6-interacting/CAST family member 2 |
chr13_+_42834989 | 33.46 |
ENSMUST00000149235.8
|
Phactr1
|
phosphatase and actin regulator 1 |
chr1_+_66360865 | 33.02 |
ENSMUST00000114013.8
|
Map2
|
microtubule-associated protein 2 |
chr3_+_18108313 | 32.60 |
ENSMUST00000026120.8
|
Bhlhe22
|
basic helix-loop-helix family, member e22 |
chr15_+_21111428 | 32.40 |
ENSMUST00000075132.8
|
Cdh12
|
cadherin 12 |
chr9_+_32027335 | 31.87 |
ENSMUST00000174641.8
|
Arhgap32
|
Rho GTPase activating protein 32 |
chr15_-_8740218 | 31.67 |
ENSMUST00000005493.14
|
Slc1a3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr3_+_67799510 | 31.48 |
ENSMUST00000063263.5
ENSMUST00000182006.4 |
Iqcj
Iqschfp
|
IQ motif containing J Iqcj and Schip1 fusion protein |
chr2_+_38231080 | 30.99 |
ENSMUST00000133661.8
|
Lhx2
|
LIM homeobox protein 2 |
chrM_+_8603 | 30.86 |
ENSMUST00000082409.1
|
mt-Co3
|
mitochondrially encoded cytochrome c oxidase III |
chr11_-_79394904 | 30.22 |
ENSMUST00000164465.3
|
Omg
|
oligodendrocyte myelin glycoprotein |
chr3_-_33136153 | 30.15 |
ENSMUST00000108225.10
|
Pex5l
|
peroxisomal biogenesis factor 5-like |
chr6_-_13839914 | 30.02 |
ENSMUST00000060442.14
|
Gpr85
|
G protein-coupled receptor 85 |
chr9_-_112016834 | 29.97 |
ENSMUST00000111872.9
ENSMUST00000164754.9 |
Arpp21
|
cyclic AMP-regulated phosphoprotein, 21 |
chr4_-_110144676 | 29.85 |
ENSMUST00000106598.8
ENSMUST00000102723.11 ENSMUST00000153906.2 |
Elavl4
|
ELAV like RNA binding protein 4 |
chr3_+_55369384 | 29.80 |
ENSMUST00000200352.2
|
Dclk1
|
doublecortin-like kinase 1 |
chrM_+_7779 | 29.59 |
ENSMUST00000082408.1
|
mt-Atp6
|
mitochondrially encoded ATP synthase 6 |
chr15_-_37459570 | 29.35 |
ENSMUST00000119730.8
ENSMUST00000120746.8 |
Ncald
|
neurocalcin delta |
chrM_+_7758 | 29.26 |
ENSMUST00000082407.1
|
mt-Atp8
|
mitochondrially encoded ATP synthase 8 |
chr3_+_55369149 | 29.11 |
ENSMUST00000199585.5
ENSMUST00000070418.9 |
Dclk1
|
doublecortin-like kinase 1 |
chr4_+_101365144 | 29.08 |
ENSMUST00000149047.8
ENSMUST00000106929.10 |
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6 |
chr3_-_26187883 | 29.07 |
ENSMUST00000108308.10
ENSMUST00000075054.10 |
Nlgn1
|
neuroligin 1 |
chr10_-_63926044 | 28.90 |
ENSMUST00000105439.2
|
Lrrtm3
|
leucine rich repeat transmembrane neuronal 3 |
chr18_+_69633741 | 28.67 |
ENSMUST00000207214.2
ENSMUST00000201094.4 ENSMUST00000200703.4 ENSMUST00000202765.4 |
Tcf4
|
transcription factor 4 |
chrM_+_10167 | 28.66 |
ENSMUST00000082414.1
|
mt-Nd4
|
mitochondrially encoded NADH dehydrogenase 4 |
chr14_-_9015639 | 28.32 |
ENSMUST00000112656.4
|
Synpr
|
synaptoporin |
chr10_+_90412432 | 28.30 |
ENSMUST00000182786.8
ENSMUST00000182600.8 |
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr10_+_90412827 | 28.17 |
ENSMUST00000182550.8
ENSMUST00000099364.12 |
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr3_+_114874614 | 28.14 |
ENSMUST00000051309.9
|
Olfm3
|
olfactomedin 3 |
chr2_+_65760477 | 28.02 |
ENSMUST00000176109.8
|
Csrnp3
|
cysteine-serine-rich nuclear protein 3 |
chr1_+_81055201 | 27.98 |
ENSMUST00000123285.2
|
Nyap2
|
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
chr14_+_75693396 | 27.61 |
ENSMUST00000164848.3
|
Siah3
|
siah E3 ubiquitin protein ligase family member 3 |
chr3_+_75982890 | 27.21 |
ENSMUST00000160261.8
|
Fstl5
|
follistatin-like 5 |
chr6_+_96090127 | 27.04 |
ENSMUST00000122120.8
|
Tafa1
|
TAFA chemokine like family member 1 |
chr3_+_64856617 | 26.99 |
ENSMUST00000238901.2
|
Kcnab1
|
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
chr3_+_7494108 | 26.94 |
ENSMUST00000193330.2
|
Pkia
|
protein kinase inhibitor, alpha |
chr16_+_6887689 | 26.59 |
ENSMUST00000229741.2
|
Rbfox1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr6_+_79995860 | 26.18 |
ENSMUST00000147663.8
ENSMUST00000128718.8 ENSMUST00000126005.8 ENSMUST00000133918.8 |
Lrrtm4
|
leucine rich repeat transmembrane neuronal 4 |
chr10_+_90412570 | 26.00 |
ENSMUST00000182430.8
ENSMUST00000182960.8 ENSMUST00000182045.2 ENSMUST00000182083.2 |
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr1_+_179788675 | 25.76 |
ENSMUST00000076687.12
ENSMUST00000097450.10 ENSMUST00000212756.2 |
Cdc42bpa
|
CDC42 binding protein kinase alpha |
chr2_-_32976378 | 25.63 |
ENSMUST00000049618.9
|
Garnl3
|
GTPase activating RANGAP domain-like 3 |
chr2_-_79959178 | 25.44 |
ENSMUST00000102654.11
ENSMUST00000102655.10 |
Pde1a
|
phosphodiesterase 1A, calmodulin-dependent |
chr18_-_22983794 | 25.31 |
ENSMUST00000092015.11
ENSMUST00000069215.13 |
Nol4
|
nucleolar protein 4 |
chr8_+_59364789 | 25.08 |
ENSMUST00000062978.7
|
BC030500
|
cDNA sequence BC030500 |
chr14_-_124914516 | 25.02 |
ENSMUST00000095529.10
|
Fgf14
|
fibroblast growth factor 14 |
chr11_-_41891359 | 24.86 |
ENSMUST00000070735.10
|
Gabrg2
|
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
chr10_+_90412638 | 24.70 |
ENSMUST00000183136.8
ENSMUST00000182595.8 |
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr12_+_38833454 | 24.60 |
ENSMUST00000161980.8
ENSMUST00000160701.8 |
Etv1
|
ets variant 1 |
chr11_+_77821626 | 24.41 |
ENSMUST00000093995.10
ENSMUST00000000646.14 |
Sez6
|
seizure related gene 6 |
chr12_+_38833501 | 24.27 |
ENSMUST00000159334.8
|
Etv1
|
ets variant 1 |
chr2_+_14393127 | 24.21 |
ENSMUST00000114731.8
ENSMUST00000082290.8 |
Slc39a12
|
solute carrier family 39 (zinc transporter), member 12 |
chr11_+_29668563 | 23.99 |
ENSMUST00000060992.6
|
Rtn4
|
reticulon 4 |
chr14_-_109151590 | 23.87 |
ENSMUST00000100322.4
|
Slitrk1
|
SLIT and NTRK-like family, member 1 |
chr10_-_108846816 | 23.68 |
ENSMUST00000105276.8
ENSMUST00000064054.14 |
Syt1
|
synaptotagmin I |
chr17_+_70829144 | 23.52 |
ENSMUST00000140728.8
|
Dlgap1
|
DLG associated protein 1 |
chr15_+_39255185 | 23.44 |
ENSMUST00000228839.2
|
Rims2
|
regulating synaptic membrane exocytosis 2 |
chr15_+_92059224 | 23.41 |
ENSMUST00000068378.6
|
Cntn1
|
contactin 1 |
chr2_+_96148418 | 23.37 |
ENSMUST00000135431.8
ENSMUST00000162807.9 |
Lrrc4c
|
leucine rich repeat containing 4C |
chr3_+_84859453 | 23.29 |
ENSMUST00000029727.8
|
Fbxw7
|
F-box and WD-40 domain protein 7 |
chrX_-_102230225 | 22.79 |
ENSMUST00000121720.2
|
Nap1l2
|
nucleosome assembly protein 1-like 2 |
chr13_-_78344492 | 22.62 |
ENSMUST00000125176.3
|
Nr2f1
|
nuclear receptor subfamily 2, group F, member 1 |
chr2_+_21372338 | 22.36 |
ENSMUST00000055946.8
|
Gpr158
|
G protein-coupled receptor 158 |
chr2_+_71359000 | 22.28 |
ENSMUST00000126400.2
|
Dlx1
|
distal-less homeobox 1 |
chr17_+_17622934 | 22.11 |
ENSMUST00000115576.3
|
Lix1
|
limb and CNS expressed 1 |
chr3_-_141687987 | 22.07 |
ENSMUST00000029948.15
|
Bmpr1b
|
bone morphogenetic protein receptor, type 1B |
chr6_-_138399896 | 21.98 |
ENSMUST00000161450.8
ENSMUST00000163024.8 ENSMUST00000162185.8 |
Lmo3
|
LIM domain only 3 |
chr3_+_129974531 | 21.89 |
ENSMUST00000080335.11
ENSMUST00000106353.2 |
Col25a1
|
collagen, type XXV, alpha 1 |
chr4_+_9269285 | 21.87 |
ENSMUST00000038841.14
|
Clvs1
|
clavesin 1 |
chr5_+_81169049 | 21.85 |
ENSMUST00000117253.8
ENSMUST00000120128.8 |
Adgrl3
|
adhesion G protein-coupled receptor L3 |
chr5_+_107645626 | 21.79 |
ENSMUST00000152474.8
ENSMUST00000060553.8 |
Btbd8
|
BTB (POZ) domain containing 8 |
chr12_+_103524690 | 21.73 |
ENSMUST00000187155.7
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr10_-_6930376 | 21.51 |
ENSMUST00000105617.8
|
Ipcef1
|
interaction protein for cytohesin exchange factors 1 |
chr11_+_16207705 | 21.49 |
ENSMUST00000109645.9
ENSMUST00000109647.3 |
Vstm2a
|
V-set and transmembrane domain containing 2A |
chr13_-_99653045 | 21.40 |
ENSMUST00000064762.6
|
Map1b
|
microtubule-associated protein 1B |
chr2_+_102488985 | 21.17 |
ENSMUST00000080210.10
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr4_+_5724305 | 20.96 |
ENSMUST00000108380.2
|
Fam110b
|
family with sequence similarity 110, member B |
chr10_-_49659355 | 20.96 |
ENSMUST00000105484.10
ENSMUST00000218598.2 ENSMUST00000079751.9 ENSMUST00000218441.2 |
Grik2
|
glutamate receptor, ionotropic, kainate 2 (beta 2) |
chr6_+_79995994 | 20.87 |
ENSMUST00000126399.2
ENSMUST00000136421.2 |
Lrrtm4
|
leucine rich repeat transmembrane neuronal 4 |
chr6_+_106095726 | 20.79 |
ENSMUST00000113258.8
ENSMUST00000079416.6 |
Cntn4
|
contactin 4 |
chr14_-_28691423 | 20.71 |
ENSMUST00000225985.2
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chr7_+_100435548 | 20.71 |
ENSMUST00000216021.2
|
Fam168a
|
family with sequence similarity 168, member A |
chr16_-_42160957 | 20.60 |
ENSMUST00000102817.5
|
Gap43
|
growth associated protein 43 |
chr9_+_37278647 | 20.52 |
ENSMUST00000051839.9
|
Hepacam
|
hepatocyte cell adhesion molecule |
chr17_+_93506435 | 20.36 |
ENSMUST00000234646.2
ENSMUST00000234081.2 |
Adcyap1
|
adenylate cyclase activating polypeptide 1 |
chr19_+_38252984 | 20.29 |
ENSMUST00000198518.5
ENSMUST00000199812.5 |
Lgi1
|
leucine-rich repeat LGI family, member 1 |
chr10_-_70491764 | 20.25 |
ENSMUST00000162144.2
ENSMUST00000162793.8 |
Phyhipl
|
phytanoyl-CoA hydroxylase interacting protein-like |
chr12_+_29578354 | 20.18 |
ENSMUST00000218583.2
ENSMUST00000049784.17 |
Myt1l
|
myelin transcription factor 1-like |
chr4_+_102446883 | 20.13 |
ENSMUST00000097949.11
ENSMUST00000106901.2 |
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr2_+_65451100 | 20.06 |
ENSMUST00000144254.6
ENSMUST00000028377.14 |
Scn2a
|
sodium channel, voltage-gated, type II, alpha |
chr5_-_84565218 | 19.91 |
ENSMUST00000113401.4
|
Epha5
|
Eph receptor A5 |
chr18_+_59195534 | 19.65 |
ENSMUST00000058633.9
ENSMUST00000175897.8 ENSMUST00000118510.8 ENSMUST00000175830.2 |
Minar2
|
membrane integral NOTCH2 associated receptor 2 |
chr11_-_42073737 | 19.63 |
ENSMUST00000206085.2
ENSMUST00000020707.12 ENSMUST00000132971.3 |
Gabra1
|
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
chr13_+_93444514 | 19.62 |
ENSMUST00000079086.8
|
Homer1
|
homer scaffolding protein 1 |
chrM_+_9870 | 19.59 |
ENSMUST00000084013.1
|
mt-Nd4l
|
mitochondrially encoded NADH dehydrogenase 4L |
chr4_+_101365052 | 19.50 |
ENSMUST00000038207.12
|
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6 |
chr18_-_31580436 | 19.49 |
ENSMUST00000025110.5
|
Syt4
|
synaptotagmin IV |
chr19_+_22670134 | 19.22 |
ENSMUST00000237470.2
ENSMUST00000099564.10 ENSMUST00000099569.10 ENSMUST00000099566.5 ENSMUST00000235712.2 |
Trpm3
|
transient receptor potential cation channel, subfamily M, member 3 |
chr19_+_26728339 | 19.20 |
ENSMUST00000175953.3
|
Smarca2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr6_-_138398376 | 19.03 |
ENSMUST00000163065.8
|
Lmo3
|
LIM domain only 3 |
chr17_+_3532455 | 18.97 |
ENSMUST00000227604.2
|
Tiam2
|
T cell lymphoma invasion and metastasis 2 |
chr17_+_70828649 | 18.96 |
ENSMUST00000233283.2
|
Dlgap1
|
DLG associated protein 1 |
chr2_-_110591909 | 18.94 |
ENSMUST00000140777.2
|
Ano3
|
anoctamin 3 |
chrM_+_9459 | 18.93 |
ENSMUST00000082411.1
|
mt-Nd3
|
mitochondrially encoded NADH dehydrogenase 3 |
chr4_-_11965691 | 18.90 |
ENSMUST00000108301.8
ENSMUST00000095144.10 ENSMUST00000108302.8 |
Pdp1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr13_+_76727787 | 18.90 |
ENSMUST00000126960.8
ENSMUST00000109583.9 |
Mctp1
|
multiple C2 domains, transmembrane 1 |
chr4_-_35845204 | 18.83 |
ENSMUST00000164772.8
ENSMUST00000065173.9 |
Lingo2
|
leucine rich repeat and Ig domain containing 2 |
chr2_+_65499097 | 18.77 |
ENSMUST00000200829.4
|
Scn2a
|
sodium channel, voltage-gated, type II, alpha |
chr16_+_20511991 | 18.74 |
ENSMUST00000149543.9
ENSMUST00000232207.2 ENSMUST00000118919.9 |
Fam131a
|
family with sequence similarity 131, member A |
chr2_-_17465410 | 18.66 |
ENSMUST00000145492.2
|
Nebl
|
nebulette |
chr5_+_117979899 | 18.57 |
ENSMUST00000142742.9
|
Nos1
|
nitric oxide synthase 1, neuronal |
chrX_-_23132991 | 18.54 |
ENSMUST00000115316.9
|
Klhl13
|
kelch-like 13 |
chr5_+_14075281 | 18.40 |
ENSMUST00000073957.8
|
Sema3e
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
chr15_+_16728842 | 18.40 |
ENSMUST00000228307.2
|
Cdh9
|
cadherin 9 |
chr13_-_105191403 | 18.28 |
ENSMUST00000063551.7
|
Rgs7bp
|
regulator of G-protein signalling 7 binding protein |
chr14_+_10123804 | 17.93 |
ENSMUST00000022262.6
ENSMUST00000224714.2 |
Fezf2
|
Fez family zinc finger 2 |
chr2_+_67935015 | 17.90 |
ENSMUST00000042456.4
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr10_+_90412539 | 17.90 |
ENSMUST00000182284.8
|
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr7_+_126549859 | 17.89 |
ENSMUST00000106333.8
|
Sez6l2
|
seizure related 6 homolog like 2 |
chr16_-_29360301 | 17.78 |
ENSMUST00000057018.15
ENSMUST00000182627.8 |
Atp13a4
|
ATPase type 13A4 |
chr1_-_132635042 | 17.76 |
ENSMUST00000043189.14
|
Nfasc
|
neurofascin |
chr2_-_73456080 | 17.74 |
ENSMUST00000070579.7
|
Chn1
|
chimerin 1 |
chr1_+_34044940 | 17.71 |
ENSMUST00000187486.7
ENSMUST00000182697.8 |
Dst
|
dystonin |
chr2_-_79959802 | 17.66 |
ENSMUST00000102653.8
|
Pde1a
|
phosphodiesterase 1A, calmodulin-dependent |
chr7_-_118042772 | 17.62 |
ENSMUST00000081574.8
|
Syt17
|
synaptotagmin XVII |
chr5_-_5315968 | 17.58 |
ENSMUST00000115451.8
ENSMUST00000115452.8 ENSMUST00000131392.8 |
Cdk14
|
cyclin-dependent kinase 14 |
chr4_+_15881256 | 17.57 |
ENSMUST00000029876.2
|
Calb1
|
calbindin 1 |
chr17_+_44263890 | 17.54 |
ENSMUST00000177857.9
ENSMUST00000044792.6 |
Rcan2
|
regulator of calcineurin 2 |
chr2_+_70392351 | 17.49 |
ENSMUST00000094934.11
|
Gad1
|
glutamate decarboxylase 1 |
chr1_+_128079543 | 17.44 |
ENSMUST00000189317.3
|
R3hdm1
|
R3H domain containing 1 |
chr18_-_15284476 | 17.28 |
ENSMUST00000025992.7
|
Kctd1
|
potassium channel tetramerisation domain containing 1 |
chr7_+_54485336 | 17.21 |
ENSMUST00000082373.8
|
Luzp2
|
leucine zipper protein 2 |
chr2_-_65397850 | 17.21 |
ENSMUST00000238483.2
ENSMUST00000100069.9 |
Scn3a
|
sodium channel, voltage-gated, type III, alpha |
chr5_-_49046874 | 17.19 |
ENSMUST00000176978.8
|
Kcnip4
|
Kv channel interacting protein 4 |
chr3_-_152687877 | 17.08 |
ENSMUST00000044278.6
|
St6galnac5
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
chr18_+_59195354 | 17.06 |
ENSMUST00000165666.9
|
Minar2
|
membrane integral NOTCH2 associated receptor 2 |
chr7_+_126549692 | 17.06 |
ENSMUST00000106335.8
ENSMUST00000146017.3 |
Sez6l2
|
seizure related 6 homolog like 2 |
chr7_+_143792455 | 16.93 |
ENSMUST00000239495.2
|
Shank2
|
SH3 and multiple ankyrin repeat domains 2 |
chr17_+_44264130 | 16.88 |
ENSMUST00000229240.2
|
Rcan2
|
regulator of calcineurin 2 |
chr1_+_66361252 | 16.86 |
ENSMUST00000123647.8
|
Map2
|
microtubule-associated protein 2 |
chr11_-_30148230 | 16.85 |
ENSMUST00000102838.10
|
Sptbn1
|
spectrin beta, non-erythrocytic 1 |
chr13_+_83652150 | 16.82 |
ENSMUST00000198199.5
|
Mef2c
|
myocyte enhancer factor 2C |
chr3_+_8574420 | 16.80 |
ENSMUST00000029002.9
|
Stmn2
|
stathmin-like 2 |
chr6_+_29859372 | 16.76 |
ENSMUST00000115238.10
|
Ahcyl2
|
S-adenosylhomocysteine hydrolase-like 2 |
chr3_-_80710097 | 16.72 |
ENSMUST00000075316.10
ENSMUST00000107745.8 |
Gria2
|
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
chr15_+_22549108 | 16.70 |
ENSMUST00000163361.8
|
Cdh18
|
cadherin 18 |
chr12_+_69954506 | 16.69 |
ENSMUST00000223456.2
|
Atl1
|
atlastin GTPase 1 |
chr1_-_132635078 | 16.68 |
ENSMUST00000187861.7
|
Nfasc
|
neurofascin |
chr2_-_45001141 | 16.67 |
ENSMUST00000201969.4
ENSMUST00000201623.4 |
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr7_+_126550009 | 16.63 |
ENSMUST00000106332.3
|
Sez6l2
|
seizure related 6 homolog like 2 |
chr3_-_79053182 | 16.60 |
ENSMUST00000118340.7
|
Rapgef2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
chr10_-_20600442 | 16.59 |
ENSMUST00000170265.8
|
Pde7b
|
phosphodiesterase 7B |
chr10_+_29019645 | 16.58 |
ENSMUST00000092629.4
|
Soga3
|
SOGA family member 3 |
chr8_-_34237752 | 16.57 |
ENSMUST00000179364.3
|
Smim18
|
small integral membrane protein 18 |
chr15_-_77037972 | 16.54 |
ENSMUST00000111581.4
ENSMUST00000166610.8 |
Rbfox2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr14_-_9015757 | 16.52 |
ENSMUST00000153954.8
|
Synpr
|
synaptoporin |
chr7_-_66915756 | 16.49 |
ENSMUST00000207715.2
|
Mef2a
|
myocyte enhancer factor 2A |
chr2_-_32977182 | 16.46 |
ENSMUST00000102810.10
|
Garnl3
|
GTPase activating RANGAP domain-like 3 |
chr7_+_90739904 | 16.46 |
ENSMUST00000107196.10
ENSMUST00000074273.10 |
Dlg2
|
discs large MAGUK scaffold protein 2 |
chr8_+_24159669 | 16.43 |
ENSMUST00000042352.11
ENSMUST00000207301.2 |
Zmat4
|
zinc finger, matrin type 4 |
chr11_+_31950452 | 16.34 |
ENSMUST00000109409.8
ENSMUST00000020537.9 |
Nsg2
|
neuron specific gene family member 2 |
chr11_-_81859241 | 16.33 |
ENSMUST00000066197.7
|
Asic2
|
acid-sensing (proton-gated) ion channel 2 |
chr6_+_104469751 | 16.30 |
ENSMUST00000161446.2
ENSMUST00000161070.8 ENSMUST00000089215.12 |
Cntn6
|
contactin 6 |
chr12_+_38830283 | 16.30 |
ENSMUST00000162563.8
ENSMUST00000161164.8 ENSMUST00000160996.8 |
Etv1
|
ets variant 1 |
chr16_-_45544960 | 16.23 |
ENSMUST00000096057.5
|
Tagln3
|
transgelin 3 |
chr11_+_98632953 | 16.16 |
ENSMUST00000153043.8
|
Thra
|
thyroid hormone receptor alpha |
chr10_-_33500583 | 16.07 |
ENSMUST00000161692.2
ENSMUST00000160299.2 ENSMUST00000019920.13 |
Clvs2
|
clavesin 2 |
chr13_+_83672654 | 16.05 |
ENSMUST00000199019.5
|
Mef2c
|
myocyte enhancer factor 2C |
chrX_-_74621828 | 16.02 |
ENSMUST00000033545.6
|
Rab39b
|
RAB39B, member RAS oncogene family |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.8 | 237.8 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
18.7 | 56.2 | GO:0061193 | taste bud development(GO:0061193) |
16.6 | 182.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
15.6 | 77.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
15.5 | 46.4 | GO:0097115 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
11.8 | 70.6 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
9.3 | 18.6 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
9.3 | 55.6 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
9.2 | 36.6 | GO:0007412 | axon target recognition(GO:0007412) |
9.1 | 9.1 | GO:0030578 | PML body organization(GO:0030578) |
8.8 | 26.5 | GO:1902868 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
8.2 | 49.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
7.7 | 176.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
7.5 | 67.8 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
7.3 | 51.3 | GO:0021764 | amygdala development(GO:0021764) |
7.3 | 36.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
7.0 | 28.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
7.0 | 27.9 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
6.9 | 27.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
6.7 | 26.7 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
6.6 | 52.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
6.6 | 32.8 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
6.5 | 32.7 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
6.2 | 80.0 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
6.1 | 30.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
6.1 | 30.5 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
6.1 | 30.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
5.8 | 75.2 | GO:0070842 | aggresome assembly(GO:0070842) |
5.7 | 28.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
5.6 | 16.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
5.5 | 16.6 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
5.5 | 38.5 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
5.5 | 11.0 | GO:0001966 | thigmotaxis(GO:0001966) |
5.5 | 43.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
5.4 | 27.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
5.3 | 15.8 | GO:0008050 | female courtship behavior(GO:0008050) |
5.2 | 20.7 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
5.1 | 36.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
5.1 | 65.7 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
5.0 | 24.9 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
4.8 | 38.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
4.8 | 14.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
4.7 | 71.0 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
4.7 | 23.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
4.6 | 41.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
4.5 | 40.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
4.4 | 92.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
4.4 | 13.2 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
4.4 | 13.1 | GO:0021629 | olfactory nerve morphogenesis(GO:0021627) olfactory nerve structural organization(GO:0021629) |
4.3 | 173.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
4.2 | 21.1 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
4.2 | 4.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
4.1 | 12.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
4.1 | 12.2 | GO:0072755 | cellular response to benomyl(GO:0072755) response to benomyl(GO:1901561) |
4.1 | 12.2 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
4.0 | 28.0 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
3.9 | 11.8 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
3.9 | 23.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
3.7 | 26.1 | GO:0061743 | motor learning(GO:0061743) |
3.7 | 11.0 | GO:0060618 | nipple development(GO:0060618) |
3.6 | 72.7 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
3.6 | 64.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
3.5 | 28.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
3.5 | 38.8 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
3.5 | 10.5 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
3.5 | 13.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
3.4 | 13.6 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
3.4 | 20.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
3.4 | 27.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
3.4 | 16.8 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
3.3 | 46.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
3.3 | 13.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
3.3 | 23.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
3.3 | 23.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
3.3 | 16.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
3.3 | 32.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.3 | 9.8 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
3.2 | 29.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
3.2 | 25.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
3.2 | 41.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
3.1 | 12.5 | GO:1990927 | negative regulation of membrane invagination(GO:1905154) calcium ion regulated lysosome exocytosis(GO:1990927) |
3.1 | 65.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
3.1 | 33.7 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
3.1 | 9.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
3.0 | 15.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
3.0 | 11.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.9 | 20.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.9 | 26.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
2.9 | 20.0 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
2.9 | 77.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
2.8 | 22.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
2.8 | 14.2 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
2.8 | 11.3 | GO:1904937 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
2.8 | 8.4 | GO:1903210 | glomerular visceral epithelial cell apoptotic process(GO:1903210) regulation of glomerular visceral epithelial cell apoptotic process(GO:1904633) positive regulation of glomerular visceral epithelial cell apoptotic process(GO:1904635) positive regulation of progesterone biosynthetic process(GO:2000184) |
2.8 | 8.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.8 | 11.1 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
2.8 | 11.0 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
2.7 | 13.7 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
2.7 | 8.2 | GO:0097494 | regulation of vesicle size(GO:0097494) |
2.7 | 24.4 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
2.7 | 18.9 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
2.7 | 24.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
2.7 | 8.0 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
2.6 | 55.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
2.6 | 7.9 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
2.6 | 34.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
2.6 | 73.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
2.6 | 114.6 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
2.6 | 12.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
2.5 | 15.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
2.5 | 52.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.4 | 72.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
2.4 | 28.9 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
2.4 | 7.2 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
2.4 | 14.2 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
2.4 | 14.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
2.3 | 21.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.3 | 9.4 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
2.3 | 16.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.3 | 81.6 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
2.3 | 7.0 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
2.3 | 6.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
2.3 | 85.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.3 | 9.1 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.3 | 6.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
2.2 | 57.9 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
2.2 | 48.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.2 | 74.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
2.2 | 52.2 | GO:0001553 | luteinization(GO:0001553) |
2.1 | 4.3 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
2.1 | 8.5 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
2.1 | 8.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
2.1 | 6.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
2.1 | 10.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.1 | 33.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
2.1 | 41.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
2.1 | 10.3 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
2.0 | 14.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
2.0 | 12.1 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
2.0 | 4.0 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) regulation of cellular amino acid biosynthetic process(GO:2000282) |
2.0 | 9.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
2.0 | 3.9 | GO:0030421 | defecation(GO:0030421) regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
2.0 | 7.8 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
1.9 | 13.3 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
1.9 | 26.4 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
1.9 | 340.8 | GO:0007416 | synapse assembly(GO:0007416) |
1.9 | 7.5 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
1.9 | 1.9 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
1.9 | 1.9 | GO:0009441 | glycolate metabolic process(GO:0009441) |
1.9 | 5.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
1.8 | 16.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.8 | 9.2 | GO:0070295 | renal water absorption(GO:0070295) |
1.8 | 7.4 | GO:1904700 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
1.8 | 9.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.8 | 7.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
1.8 | 18.2 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.8 | 14.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
1.8 | 10.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.8 | 3.5 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
1.7 | 8.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.7 | 6.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.7 | 32.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.7 | 15.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.7 | 6.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.7 | 31.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.7 | 81.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.7 | 13.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.6 | 26.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.6 | 6.4 | GO:0072021 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
1.6 | 9.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.6 | 9.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.6 | 3.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.6 | 6.3 | GO:0071376 | positive regulation of mast cell cytokine production(GO:0032765) response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.6 | 10.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.5 | 21.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.5 | 4.6 | GO:1904268 | positive regulation of Schwann cell migration(GO:1900149) regulation of Schwann cell chemotaxis(GO:1904266) positive regulation of Schwann cell chemotaxis(GO:1904268) Schwann cell chemotaxis(GO:1990751) |
1.5 | 15.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.5 | 4.6 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
1.5 | 15.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.5 | 31.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.5 | 12.0 | GO:1902564 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
1.5 | 10.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.5 | 2.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.4 | 172.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.4 | 2.9 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
1.4 | 8.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
1.4 | 25.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.4 | 8.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.4 | 8.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.4 | 29.0 | GO:0007019 | microtubule depolymerization(GO:0007019) |
1.4 | 9.5 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
1.4 | 4.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.3 | 9.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.3 | 12.0 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.3 | 1.3 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.3 | 4.0 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
1.3 | 13.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.3 | 3.9 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
1.3 | 8.9 | GO:0033762 | response to glucagon(GO:0033762) |
1.3 | 14.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) gamma-aminobutyric acid transport(GO:0015812) |
1.3 | 7.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
1.3 | 3.8 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
1.3 | 22.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.3 | 5.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
1.2 | 3.7 | GO:1904306 | positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
1.2 | 7.3 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
1.2 | 6.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.2 | 7.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.2 | 18.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.2 | 6.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
1.2 | 3.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.2 | 10.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
1.2 | 7.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.2 | 7.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.2 | 5.8 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
1.1 | 8.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.1 | 14.8 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
1.1 | 7.9 | GO:0051012 | microtubule sliding(GO:0051012) |
1.1 | 6.8 | GO:0002188 | translation reinitiation(GO:0002188) |
1.1 | 6.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.1 | 3.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
1.1 | 4.4 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.1 | 4.4 | GO:0009305 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
1.1 | 10.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.1 | 57.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.1 | 5.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.1 | 8.5 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
1.1 | 27.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 24.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
1.1 | 4.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.1 | 4.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.0 | 6.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.0 | 1.0 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
1.0 | 48.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
1.0 | 3.0 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
1.0 | 4.0 | GO:0038016 | insulin receptor internalization(GO:0038016) |
1.0 | 6.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
1.0 | 3.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.0 | 15.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
1.0 | 61.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
1.0 | 1.9 | GO:0007614 | short-term memory(GO:0007614) |
1.0 | 13.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.9 | 27.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.9 | 23.4 | GO:0021766 | hippocampus development(GO:0021766) |
0.9 | 4.7 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
0.9 | 5.6 | GO:0015676 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.9 | 2.8 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.9 | 20.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.9 | 1.8 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
0.9 | 11.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.9 | 22.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.9 | 1.8 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.9 | 17.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.9 | 14.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.9 | 28.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.9 | 7.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.9 | 7.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.9 | 36.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.9 | 6.8 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.9 | 5.1 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.8 | 1.7 | GO:0003032 | detection of oxygen(GO:0003032) |
0.8 | 6.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.8 | 5.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.8 | 6.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.8 | 6.6 | GO:0031179 | peptide modification(GO:0031179) |
0.8 | 1.6 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.8 | 4.9 | GO:0097475 | motor neuron migration(GO:0097475) |
0.8 | 31.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.8 | 53.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.8 | 1.6 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.8 | 8.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.8 | 3.9 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.8 | 3.9 | GO:0060023 | soft palate development(GO:0060023) |
0.8 | 111.0 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.8 | 2.3 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.8 | 25.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.8 | 3.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.8 | 11.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.8 | 3.1 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.8 | 98.5 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.8 | 16.6 | GO:0030325 | adrenal gland development(GO:0030325) |
0.7 | 34.4 | GO:0001662 | behavioral fear response(GO:0001662) |
0.7 | 1.5 | GO:0050955 | thermoception(GO:0050955) |
0.7 | 1.5 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.7 | 2.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.7 | 50.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.7 | 2.1 | GO:1900135 | regulation of renin secretion into blood stream(GO:1900133) positive regulation of renin secretion into blood stream(GO:1900135) |
0.7 | 0.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.7 | 47.3 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.7 | 6.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.7 | 10.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.7 | 65.6 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.7 | 6.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.7 | 5.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.7 | 2.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.7 | 3.3 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.6 | 1.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 4.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.6 | 4.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 1.9 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.6 | 5.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.6 | 5.0 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.6 | 2.5 | GO:0021756 | striatum development(GO:0021756) |
0.6 | 3.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.6 | 21.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.6 | 4.8 | GO:0060613 | fat pad development(GO:0060613) |
0.6 | 6.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.6 | 3.6 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.6 | 2.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.6 | 15.4 | GO:0048665 | neuron fate specification(GO:0048665) |
0.6 | 1.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.6 | 1.2 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.6 | 8.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.6 | 1.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.6 | 5.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.6 | 2.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.6 | 5.1 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 3.8 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.5 | 34.0 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.5 | 21.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.5 | 1.6 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.5 | 55.1 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.5 | 6.7 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 19.1 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.5 | 3.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.5 | 2.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 12.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.5 | 15.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.5 | 15.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.5 | 2.0 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.5 | 2.5 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.5 | 1.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.5 | 0.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.5 | 1.9 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.5 | 14.4 | GO:0008542 | visual learning(GO:0008542) |
0.5 | 2.9 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.5 | 2.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.5 | 4.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 1.9 | GO:0072362 | regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
0.5 | 2.4 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.5 | 1.4 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.5 | 1.8 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.5 | 4.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.5 | 12.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 9.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.4 | 2.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 31.0 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.4 | 4.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 14.4 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.4 | 1.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.4 | 1.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.4 | 48.3 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.4 | 4.8 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 7.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.4 | 3.0 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.4 | 2.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 2.5 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.4 | 3.4 | GO:0044805 | late nucleophagy(GO:0044805) |
0.4 | 2.9 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 11.3 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 9.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.4 | 3.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 4.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.4 | 13.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 11.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.4 | 0.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 3.1 | GO:0001964 | startle response(GO:0001964) |
0.4 | 6.9 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 26.2 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.4 | 1.1 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.4 | 25.4 | GO:0016358 | dendrite development(GO:0016358) |
0.4 | 3.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 3.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 3.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 31.7 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.4 | 5.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 2.1 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 1.0 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.3 | 5.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 6.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 8.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.3 | 2.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 13.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 2.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 3.0 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 5.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 7.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.3 | 2.9 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 0.9 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.3 | 2.2 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 1.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 12.0 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.3 | 0.9 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 1.5 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.3 | 1.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.3 | 3.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 0.6 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.3 | 1.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.3 | 1.5 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.3 | 6.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 4.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.3 | 7.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.3 | 4.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.4 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 2.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 5.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 0.8 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) positive regulation of gap junction assembly(GO:1903598) |
0.3 | 3.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 1.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 1.6 | GO:1900245 | blood vessel maturation(GO:0001955) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 1.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 4.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.3 | 1.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 1.0 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 1.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 5.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 1.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 2.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 6.0 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 3.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.7 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.2 | 2.0 | GO:1901978 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 7.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 36.6 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.2 | 0.6 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 0.9 | GO:0002371 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) necroptotic signaling pathway(GO:0097527) |
0.2 | 1.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.2 | 3.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 2.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 2.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 4.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 6.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 5.0 | GO:0032094 | response to food(GO:0032094) |
0.2 | 5.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 0.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 3.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.2 | 8.4 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.2 | 41.2 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.2 | 4.3 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 1.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 6.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.2 | 17.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.2 | 6.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 3.7 | GO:0071385 | cellular response to glucocorticoid stimulus(GO:0071385) |
0.2 | 3.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.7 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.2 | 4.3 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.2 | 2.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 1.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 1.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 2.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 4.2 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 6.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 28.1 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.2 | 5.3 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.2 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 4.2 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 2.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 2.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 11.9 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 10.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.4 | GO:0021666 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.1 | 1.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 1.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 2.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.4 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.1 | 1.7 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 1.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 4.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 16.7 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 10.0 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 1.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.1 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 0.8 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 3.9 | GO:0007613 | memory(GO:0007613) |
0.1 | 0.7 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 3.6 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 1.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 13.2 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 1.0 | GO:0032264 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 7.3 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.5 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 1.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 1.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.6 | GO:0015840 | urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
0.1 | 2.7 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 1.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 1.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 2.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 4.9 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.1 | 1.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 2.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 2.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 1.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 1.4 | GO:0001508 | action potential(GO:0001508) |
0.1 | 2.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 1.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 1.4 | GO:1903076 | regulation of protein localization to plasma membrane(GO:1903076) |
0.1 | 0.5 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.6 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 1.6 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.7 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 1.1 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 1.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 2.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 1.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 4.4 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.1 | 0.5 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 7.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 1.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 1.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 2.4 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
0.0 | 0.2 | GO:0019452 | L-cysteine catabolic process to taurine(GO:0019452) taurine biosynthetic process(GO:0042412) |
0.0 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 0.1 | GO:0061187 | histone H4-K20 demethylation(GO:0035574) regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.0 | 1.8 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.4 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.0 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.8 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 1.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.0 | 0.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:0090070 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 36.8 | GO:0016014 | dystrobrevin complex(GO:0016014) |
11.1 | 11.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
9.9 | 89.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
9.1 | 36.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
6.9 | 34.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
6.4 | 178.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
6.3 | 119.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
5.4 | 43.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
5.1 | 30.5 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
4.9 | 78.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
4.5 | 13.6 | GO:1904511 | cortical microtubule plus-end(GO:1903754) cytoplasmic microtubule plus-end(GO:1904511) |
4.2 | 109.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
4.0 | 68.7 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
4.0 | 32.2 | GO:0033269 | internode region of axon(GO:0033269) |
3.9 | 23.4 | GO:0008091 | spectrin(GO:0008091) |
3.9 | 77.7 | GO:0031045 | dense core granule(GO:0031045) |
3.9 | 15.4 | GO:0032280 | symmetric synapse(GO:0032280) |
3.5 | 17.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
3.3 | 318.0 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
3.2 | 25.5 | GO:0031673 | H zone(GO:0031673) |
3.1 | 87.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
3.0 | 56.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
2.9 | 11.8 | GO:0097447 | dendritic tree(GO:0097447) |
2.9 | 83.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.8 | 8.4 | GO:1990843 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
2.6 | 7.9 | GO:0018444 | translation release factor complex(GO:0018444) |
2.6 | 7.9 | GO:0043512 | inhibin A complex(GO:0043512) |
2.6 | 41.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.4 | 60.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.4 | 9.5 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
2.3 | 785.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.2 | 95.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
2.1 | 8.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.1 | 70.4 | GO:0044295 | axonal growth cone(GO:0044295) |
2.1 | 24.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.9 | 59.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.9 | 27.0 | GO:1990635 | proximal dendrite(GO:1990635) |
1.8 | 212.5 | GO:0043197 | dendritic spine(GO:0043197) |
1.6 | 6.6 | GO:0014802 | terminal cisterna(GO:0014802) |
1.6 | 14.6 | GO:0043083 | synaptic cleft(GO:0043083) |
1.6 | 488.4 | GO:0060076 | excitatory synapse(GO:0060076) |
1.6 | 6.3 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
1.5 | 10.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.4 | 5.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
1.4 | 14.4 | GO:0033116 | growth cone membrane(GO:0032584) endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.4 | 35.4 | GO:0071564 | npBAF complex(GO:0071564) |
1.4 | 54.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.3 | 10.7 | GO:0005883 | neurofilament(GO:0005883) |
1.3 | 16.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.2 | 7.3 | GO:0030427 | site of polarized growth(GO:0030427) |
1.2 | 5.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.1 | 4.6 | GO:0034683 | integrin alphav-beta3 complex(GO:0034683) integrin alphav-beta8 complex(GO:0034686) |
1.1 | 3.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
1.1 | 16.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.1 | 33.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.1 | 15.0 | GO:0071437 | invadopodium(GO:0071437) |
1.0 | 4.0 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
1.0 | 96.3 | GO:0070469 | respiratory chain(GO:0070469) |
1.0 | 2.9 | GO:0044753 | amphisome(GO:0044753) |
0.9 | 29.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.9 | 5.6 | GO:0070826 | paraferritin complex(GO:0070826) |
0.9 | 227.7 | GO:0043209 | myelin sheath(GO:0043209) |
0.9 | 5.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.9 | 19.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.9 | 9.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 7.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 14.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 29.0 | GO:0030315 | T-tubule(GO:0030315) |
0.7 | 120.7 | GO:0030426 | growth cone(GO:0030426) |
0.7 | 56.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.7 | 3.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.7 | 28.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 7.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.7 | 4.2 | GO:0071547 | piP-body(GO:0071547) |
0.7 | 163.2 | GO:0030017 | sarcomere(GO:0030017) |
0.7 | 8.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 8.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 1.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.7 | 9.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 3.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 7.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 36.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.6 | 1.7 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.6 | 4.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 5.0 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.6 | 5.0 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.6 | 269.3 | GO:0045202 | synapse(GO:0045202) |
0.5 | 4.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 63.9 | GO:0016605 | PML body(GO:0016605) |
0.5 | 119.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.5 | 2.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.5 | 6.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 13.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.5 | 38.9 | GO:0042641 | actomyosin(GO:0042641) |
0.5 | 2.9 | GO:0030118 | clathrin coat(GO:0030118) |
0.5 | 301.5 | GO:0043005 | neuron projection(GO:0043005) |
0.5 | 1.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 7.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 4.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 12.9 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.4 | 34.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 4.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 1.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 11.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 2.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.4 | 5.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 2.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 4.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 3.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 15.4 | GO:0005844 | polysome(GO:0005844) |
0.3 | 1.3 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.3 | 3.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 62.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 56.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 41.2 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.3 | 2.6 | GO:0002177 | manchette(GO:0002177) |
0.3 | 4.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.3 | 0.9 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.3 | 12.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 7.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 2.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 8.6 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 21.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 14.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 2.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 4.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 13.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.3 | 3.6 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 0.8 | GO:0070992 | translation initiation complex(GO:0070992) |
0.2 | 2.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 1.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 2.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 15.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 2.9 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 1.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 2.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.7 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 3.5 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 1.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 5.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 5.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.5 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.2 | 0.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 0.2 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.2 | 2.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 19.8 | GO:0097458 | neuron part(GO:0097458) |
0.2 | 1.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 1.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 182.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 3.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 2.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 3.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 20.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 5.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.1 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 2.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.6 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 2.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 5.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 16.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 2.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 1.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 9.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 5.0 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 3.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 40.1 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 2.1 | GO:0015935 | small ribosomal subunit(GO:0015935) cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 174.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 1.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.7 | 56.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
16.6 | 16.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
16.4 | 98.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
14.4 | 43.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
10.9 | 97.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
9.7 | 38.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
8.8 | 52.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
8.3 | 223.0 | GO:0003680 | AT DNA binding(GO:0003680) |
7.8 | 23.3 | GO:0019807 | aspartoacylase activity(GO:0019807) |
7.4 | 59.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
7.0 | 28.0 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
7.0 | 55.7 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
6.7 | 107.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
6.3 | 37.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
6.3 | 37.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
5.9 | 41.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
5.8 | 52.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
5.5 | 5.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
5.4 | 37.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
5.0 | 70.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
4.9 | 43.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
4.8 | 81.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
4.7 | 18.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
4.7 | 14.0 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
4.6 | 18.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
4.5 | 17.9 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
4.2 | 12.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
4.1 | 61.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
4.1 | 12.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
3.9 | 43.1 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.9 | 38.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
3.8 | 38.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
3.7 | 18.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
3.7 | 96.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
3.6 | 28.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
3.5 | 21.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
3.5 | 10.5 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
3.3 | 125.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
3.3 | 105.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
3.3 | 9.8 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
3.2 | 35.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
3.2 | 57.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
3.2 | 35.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.2 | 94.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
3.1 | 199.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
3.0 | 12.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
3.0 | 21.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
3.0 | 127.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.9 | 5.9 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
2.9 | 31.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.9 | 2.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
2.8 | 8.5 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
2.7 | 13.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.7 | 10.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
2.6 | 10.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
2.5 | 15.2 | GO:0004359 | glutaminase activity(GO:0004359) |
2.5 | 19.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
2.5 | 51.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.4 | 12.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
2.4 | 14.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
2.3 | 94.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
2.2 | 10.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.2 | 15.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
2.2 | 30.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
2.1 | 25.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.1 | 25.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.1 | 8.5 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
2.1 | 8.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
2.0 | 8.1 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
2.0 | 85.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.0 | 7.9 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
1.9 | 185.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.9 | 18.9 | GO:0015288 | porin activity(GO:0015288) |
1.8 | 14.7 | GO:0005499 | vitamin D binding(GO:0005499) |
1.8 | 38.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
1.7 | 17.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.7 | 51.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
1.7 | 8.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.7 | 15.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.6 | 6.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
1.6 | 6.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.6 | 6.5 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
1.6 | 12.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.6 | 12.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.6 | 15.7 | GO:0038132 | neuregulin binding(GO:0038132) |
1.5 | 58.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.5 | 35.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.5 | 4.6 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.5 | 21.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.4 | 71.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.4 | 29.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.4 | 5.6 | GO:0097016 | L27 domain binding(GO:0097016) |
1.4 | 90.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
1.4 | 15.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.3 | 30.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.3 | 9.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.3 | 1.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.3 | 3.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
1.3 | 17.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
1.3 | 7.6 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
1.3 | 3.8 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
1.2 | 87.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.2 | 4.9 | GO:0070052 | collagen V binding(GO:0070052) |
1.2 | 3.7 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
1.2 | 8.3 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
1.2 | 34.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.2 | 5.8 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.1 | 10.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
1.1 | 30.4 | GO:0031489 | myosin V binding(GO:0031489) |
1.1 | 7.9 | GO:0034711 | inhibin binding(GO:0034711) |
1.1 | 6.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.1 | 8.9 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.1 | 19.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.1 | 7.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.1 | 180.2 | GO:0044325 | ion channel binding(GO:0044325) |
1.1 | 7.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
1.1 | 4.4 | GO:0004079 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
1.1 | 6.3 | GO:0055100 | adiponectin binding(GO:0055100) |
1.1 | 6.3 | GO:0019808 | polyamine binding(GO:0019808) |
1.0 | 4.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
1.0 | 51.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.0 | 18.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
1.0 | 4.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) arrestin family protein binding(GO:1990763) |
1.0 | 5.1 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
1.0 | 3.0 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
1.0 | 5.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.0 | 7.9 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.0 | 13.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.0 | 5.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.0 | 21.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.0 | 8.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.9 | 42.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.9 | 4.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.9 | 2.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.9 | 15.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.9 | 5.6 | GO:0015100 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.9 | 13.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.9 | 5.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.9 | 13.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.9 | 22.4 | GO:0004629 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.9 | 2.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.9 | 2.7 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.9 | 28.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.9 | 5.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.9 | 5.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.9 | 6.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.9 | 72.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.9 | 6.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 1.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.8 | 8.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.8 | 63.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.8 | 100.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.8 | 11.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.8 | 2.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 4.1 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.8 | 98.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.8 | 36.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.8 | 10.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 32.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.8 | 2.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.8 | 3.9 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.8 | 3.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 3.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.8 | 8.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 4.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.7 | 15.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.7 | 2.2 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.7 | 3.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.7 | 4.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 20.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 21.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 7.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.7 | 3.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.7 | 16.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 25.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 28.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.7 | 2.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.7 | 3.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.7 | 45.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.7 | 18.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.7 | 13.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.6 | 2.6 | GO:0032093 | SAM domain binding(GO:0032093) |
0.6 | 1.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.6 | 9.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.6 | 73.3 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.6 | 9.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 19.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.6 | 4.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.6 | 6.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.6 | 2.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.6 | 2.9 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.6 | 13.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 2.3 | GO:0004844 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.6 | 2.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.6 | 2.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.5 | 1.6 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.5 | 9.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 33.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 2.6 | GO:0002046 | opsin binding(GO:0002046) |
0.5 | 6.7 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 11.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 4.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 1.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 26.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.5 | 76.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.5 | 5.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 2.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.5 | 1.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.5 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.5 | 4.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 86.7 | GO:0005516 | calmodulin binding(GO:0005516) |
0.5 | 1.9 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.5 | 1.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 1.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 7.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 25.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 12.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 3.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 6.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 156.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 15.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 2.5 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 0.8 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 10.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 1.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.4 | 107.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.4 | 1.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 5.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 3.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 1.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 167.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.4 | 3.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 24.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 10.5 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 3.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 1.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 3.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 1.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 5.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 0.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 5.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 10.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 4.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 3.5 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.8 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.3 | 2.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 1.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.3 | 15.8 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.3 | 1.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.7 | GO:0008988 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.2 | 2.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 7.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 1.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 2.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 5.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 4.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 2.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 2.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 5.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 3.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 12.9 | GO:0042562 | hormone binding(GO:0042562) |
0.2 | 1.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 55.3 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.2 | 12.9 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 4.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 1.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 7.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 2.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 3.2 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 3.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 6.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 107.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 1.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 2.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 2.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 3.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.2 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 6.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 1.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 32.6 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.2 | 0.6 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.2 | 3.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.8 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 2.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.1 | 1.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 1.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 2.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 1.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 1.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 14.9 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 2.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 2.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 3.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 16.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 2.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 27.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 1.9 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 1.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 38.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 1.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 2.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 2.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 1.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 3.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 1.3 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.0 | 6.4 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.0 | 0.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.0 | 0.1 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.7 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 252.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
3.4 | 105.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
2.0 | 13.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.6 | 176.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.2 | 43.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.1 | 84.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.1 | 106.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.1 | 44.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.1 | 35.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.1 | 12.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.0 | 21.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.9 | 65.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.9 | 6.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.8 | 27.7 | PID MYC PATHWAY | C-MYC pathway |
0.8 | 26.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 12.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.7 | 21.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.6 | 45.6 | PID CDC42 PATHWAY | CDC42 signaling events |
0.6 | 32.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 70.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.6 | 7.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 9.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.6 | 2.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 8.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 4.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 9.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 26.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.5 | 46.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 1.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 17.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 1.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 16.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 18.8 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 19.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 3.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 8.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 11.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 4.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 7.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 18.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 1.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 4.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 7.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 13.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 4.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 3.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 4.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 4.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 2.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 3.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 11.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 7.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 3.3 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 4.0 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 4.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 6.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 1.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 11.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 2.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.1 | PID E2F PATHWAY | E2F transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 181.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
5.1 | 257.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
5.0 | 15.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
4.2 | 84.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.9 | 54.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
3.4 | 175.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.3 | 118.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.7 | 106.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.4 | 37.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.2 | 91.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.0 | 73.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.9 | 23.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.9 | 65.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.7 | 54.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.7 | 64.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.5 | 22.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.5 | 18.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.4 | 36.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.4 | 30.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.4 | 100.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
1.4 | 10.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.3 | 7.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.3 | 103.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
1.3 | 21.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.2 | 2.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.2 | 12.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.2 | 14.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.2 | 44.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.1 | 15.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.0 | 101.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.9 | 54.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.9 | 19.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.9 | 7.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.9 | 24.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.8 | 32.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.8 | 12.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 37.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.7 | 96.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.7 | 13.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 14.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.6 | 3.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.6 | 32.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.6 | 9.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 28.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 15.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 12.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.5 | 36.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.5 | 16.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 7.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 10.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 10.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 5.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 28.2 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.4 | 14.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 6.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 13.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 16.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 9.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 6.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 4.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 5.7 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.3 | 5.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 6.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 6.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 11.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 6.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 5.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 5.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 4.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 5.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 3.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 12.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 1.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 6.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 3.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 3.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 9.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 27.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 10.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 35.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 8.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 3.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 9.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 6.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.9 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 3.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |